JP2018512417A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018512417A5 JP2018512417A5 JP2017550154A JP2017550154A JP2018512417A5 JP 2018512417 A5 JP2018512417 A5 JP 2018512417A5 JP 2017550154 A JP2017550154 A JP 2017550154A JP 2017550154 A JP2017550154 A JP 2017550154A JP 2018512417 A5 JP2018512417 A5 JP 2018512417A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- binding protein
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562142257P | 2015-04-02 | 2015-04-02 | |
| US62/142,257 | 2015-04-02 | ||
| PCT/US2016/025336 WO2016161154A1 (en) | 2015-04-02 | 2016-03-31 | Methods for treating obesity and nonalcoholic fatty liver disease or nonalcoholic steatohepatitis using glucagon receptor antagonistic antibodies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018512417A JP2018512417A (ja) | 2018-05-17 |
| JP2018512417A5 true JP2018512417A5 (https=) | 2019-05-09 |
| JP6861641B2 JP6861641B2 (ja) | 2021-04-21 |
Family
ID=57006366
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017550154A Expired - Fee Related JP6861641B2 (ja) | 2015-04-02 | 2016-03-31 | グルカゴン受容体アンタゴニスト抗体を用いた肥満症および非アルコール性脂肪性肝疾患または非アルコール性脂肪性肝炎を治療するための方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US10752693B2 (https=) |
| EP (1) | EP3277830A4 (https=) |
| JP (1) | JP6861641B2 (https=) |
| KR (1) | KR20170138456A (https=) |
| CN (1) | CN107614695B (https=) |
| AU (1) | AU2016242935B2 (https=) |
| CA (1) | CA2980765A1 (https=) |
| MX (1) | MX392496B (https=) |
| WO (1) | WO2016161154A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3565559A4 (en) * | 2017-01-09 | 2020-07-08 | Temple University - Of The Commonwealth System of Higher Education | PHARMACEUTICAL METHODS AND COMPOSITIONS FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS |
| EP3573651A4 (en) * | 2017-01-27 | 2020-10-14 | NGM Biopharmaceuticals, Inc. | GLUCAGON RECEPTOR BINDING PROTEINS AND METHODS OF USE |
| US11352405B2 (en) * | 2017-08-09 | 2022-06-07 | Sanofi | GLP-1/glucagon receptor agonists in the treatment of fatty liver disease and steatohepatitis |
| WO2019173417A1 (en) * | 2018-03-08 | 2019-09-12 | Phanes Therapeutics, Inc. | Anti-tip-1 antibodies and uses thereof |
| CN110357959B (zh) | 2018-04-10 | 2023-02-28 | 鸿运华宁（杭州）生物医药有限公司 | Gcgr抗体及其与glp-1的融合蛋白质，以及其药物组合物和应用 |
| EP3829636A1 (en) | 2018-07-27 | 2021-06-09 | NGM Biopharmaceuticals, Inc. | Use of glucagon receptor antagonists with immunotherapeutic agent |
| CN111068042B (zh) * | 2018-10-18 | 2023-10-13 | 中山大学 | 一种多肽化合物在制备治疗非酒精性肝病、特发性肺间质纤维化和动脉硬化药物中的应用 |
| EP3876924A4 (en) * | 2018-11-06 | 2022-08-10 | Georgetown University | TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS WITH CCK INHIBITORS |
| CN115947849A (zh) | 2018-12-21 | 2023-04-11 | 江苏恒瑞医药股份有限公司 | 双特异性蛋白 |
| WO2025178928A1 (en) * | 2024-02-23 | 2025-08-28 | Remd Biotherapeutics, Inc. | Combination therapy for the treatment of obesity |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CL2007002668A1 (es) * | 2006-09-20 | 2008-05-09 | Amgen Inc | Proteina de union a antigeno que se une al receptor de glucagon humano; acido nucleico que la codifica; metodo de produccion; composicion farmaceutica que la comprende; y su uso para tratar o prevenir la diabetes tipo 2. |
| WO2009149379A2 (en) | 2008-06-05 | 2009-12-10 | Regents Of The University Of Michigan | Use of leptin for the treatment of fatty liver diseases and conditions |
| AR072160A1 (es) * | 2008-06-17 | 2010-08-11 | Univ Indiana Res & Tech Corp | Co-agonistas del receptor de glucagon/glp-1 |
| WO2013043817A1 (en) * | 2011-09-20 | 2013-03-28 | Isis Phamaceuticals, Inc. | Antisense modulation of gcgr expression |
| WO2014181229A2 (en) * | 2013-05-07 | 2014-11-13 | Rinat Neuroscience Corp. | Anti-glucagon receptor antibodies and methods of use thereof |
| WO2015189698A2 (en) * | 2014-06-08 | 2015-12-17 | Beijing Cosci-Remd Bio Med Tech Company Ltd | Methods for treating type 1 diabetes using glucagon receptor antagonistic antibodies |
-
2016
- 2016-03-31 JP JP2017550154A patent/JP6861641B2/ja not_active Expired - Fee Related
- 2016-03-31 US US15/563,162 patent/US10752693B2/en active Active
- 2016-03-31 KR KR1020177031693A patent/KR20170138456A/ko not_active Ceased
- 2016-03-31 MX MX2017012694A patent/MX392496B/es unknown
- 2016-03-31 EP EP16774227.9A patent/EP3277830A4/en not_active Ceased
- 2016-03-31 CA CA2980765A patent/CA2980765A1/en active Pending
- 2016-03-31 WO PCT/US2016/025336 patent/WO2016161154A1/en not_active Ceased
- 2016-03-31 AU AU2016242935A patent/AU2016242935B2/en not_active Ceased
- 2016-03-31 CN CN201680030380.0A patent/CN107614695B/zh not_active Expired - Fee Related
-
2020
- 2020-07-14 US US16/928,441 patent/US20200339697A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018512417A5 (https=) | ||
| US10906965B2 (en) | Methods of treating autoimmune disease or chronic inflammation wtih antibodies that bind peptidoglycan recognition protein 1 | |
| JP2021510710A5 (https=) | ||
| Fisher et al. | Generation and preclinical characterization of an antibody specific for SEMA4D | |
| US10941198B2 (en) | Human anti-IFN-α antibodies | |
| JP2017521998A (ja) | 新規多重特異性分子及びかかる多重特異性分子に基づく新規治療方法 | |
| JP2020534830A5 (https=) | ||
| SG191716A1 (en) | Neutralizing anti-ccl20 antibodies | |
| WO2022166940A1 (en) | Cldn18.2/cd3 bispecific antibodies for the therapy of cldn18.2-expressing solid tumors | |
| AU2022252731B2 (en) | Protein Binders For iRhom2 | |
| US10975144B2 (en) | CDNA encoding a monoclonal anti-IL-32 antibody and methods for the production of the antibody | |
| RU2014106933A (ru) | Способы и композиции для лечения аутоиммунных и воспалительных заболеваний | |
| JP2022500455A5 (https=) | ||
| KR20180109977A (ko) | Il-17c에 대한 항체 | |
| CN110214027A (zh) | 抗人tim-3抗体及其使用方法 | |
| JP2024533488A (ja) | 抗ヒトｃｄ３抗体及びその応用 | |
| US12252541B2 (en) | Anti-BCMA antibody and use thereof | |
| KR20240026959A (ko) | 항-ｔｒｅｍ-1 항체 | |
| EP3841122A1 (en) | Anti-sirpg compounds | |
| CA3133163C (en) | Protein binders for irhom2 | |
| WO2025232057A1 (zh) | 可结合人cd137单克隆抗体或其功能性片段及其应用 | |
| RU2022104587A (ru) | Система химерных антигенных рецепторов и ее применение | |
| RU2021119549A (ru) | Способы и фармацевтические композиции для усиления cd8+ t-клеточных иммунных ответов у субъектов, страдающих от рака |